Recombinant IL23A (Brazikumab Biosimilar) antibody

Catalog No. ABIN7488120

This anti-IL23A (Brazikumab Biosimilar) antibody is a Mammalian Cells Monoclonal antibody detecting IL23A (Brazikumab Biosimilar) in ELISA. Suitable for Human.

Quick Overview for Recombinant IL23A (Brazikumab Biosimilar) antibody (ABIN7488120)

Target: IL23A (Brazikumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL23A (Brazikumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL23A (Brazikumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Brazikumab Biosimilar - Anti-IL23A mAb

Characteristics: Antibody Type: IgG2-lambda

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG2 lambda

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL23A (Brazikumab Biosimilar)

Target: IL23A (Brazikumab Biosimilar)

Target Type: Biosimilar

Background: AMG-139,MEDI2070
Brazikumab is a human monoclonal antibody targeting IL23A that can be potentially used in the treatment of Crohn's disease (CD).

CAS-No: 1610353-18-8